In Alzheimer’s disease, current evidence implicates impaired levels of ApoE4 (which correlates with neurodegeneration while also being able to bind to metals, such as iron) in the sequestration of iron to amyloid-β deposits [48]. This evidence concerns the gene APOE and Alzheimer disease.